Andrew J. Schwab, Director, 10% Owner at Skye Bioscience, Inc. (SKYE), sold 454,026 shares at $3.42 ($1.6M) on 2025-08-22, disclosed to the SEC on 2025-08-22.
Open-market sale of $1.6M SKYE by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.57 | 2,314 | $8K | 0.5% |
| 2 | $3.57 | 58,642 | $209K | 13.3% |
| 3 | $3.57 | 58,642 | $209K | 13.3% |
| 4 | $3.42 | 6,470 | $22K | 1.4% |
| 5 | $3.42 | 163,979 | $561K | 35.7% |
| 6 | $3.42 | 163,979 |
| $561K |
| 35.7% |
| Total | $3.46 avg | 454,026 | $1.6M | 100% |
| Filing → |
| CAMP | SELL | 2026-08-31 | $1.6M | — | Filing → |
| CAMP | SELL | 2026-08-26 | $45 | — | Filing → |
| CAMP | SELL | 2026-08-21 | $880K | — | Filing → |